0001193805-20-000288.txt : 20200303
0001193805-20-000288.hdr.sgml : 20200303
20200303190936
ACCESSION NUMBER: 0001193805-20-000288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Jerrold B
CENTRAL INDEX KEY: 0001542519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36728
FILM NUMBER: 20684922
MAIL ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001368514
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 562590442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
BUSINESS PHONE: (201) 478-5552
MAIL ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
FORMER COMPANY:
FORMER CONFORMED NAME: R&R ACQUISITION VI, INC
DATE OF NAME CHANGE: 20060707
4
1
e619422_4-jgrossman.xml
X0306
4
2020-02-28
0
0001368514
ADMA BIOLOGICS, INC.
ADMA
0001542519
Grossman Jerrold B
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
1
0
0
0
Common Stock
2020-02-28
4
A
0
7500
0
A
140364
D
Common Stock
22857
I
See Footnote
Common Stock
31381
I
See Footnote
Common Stock
38294
I
See Footnote
Common Stock
175
I
See Footnote
Employee Stock Option (right to buy)
2.915
2020-02-28
4
A
0
15000
0
A
2030-02-28
Common Stock
15000
15000
D
These shares represent restricted stock units ("RSUs"), which will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting.
Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 132,864 shares of common stock owned by the reporting person.
These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
These shares are owned by the reporting person's wife.
The option vests in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
2020-03-03